Adjunct Minocyline in Treatment-resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 7, 2020

Study Completion Date

August 7, 2020

Conditions
Major Depressive Disorder
Interventions
DRUG

Minocycline

6 weeks 200mg/day Minocycline add-on

DRUG

Placebo

6 weeks Placebo add-on

Trial Locations (9)

12203

Department of Psychiatry, Charité - Campus Benjamin Franklin, Berlin

37075

Department of Psychiatry, University Medical Center Göttingen, Göttingen

69115

Heidelberg University Hospital, Department of Psychiatry, Heidelberg

80336

Department of Psychiatry, LMU Munich, Munich

80804

Max Planck Institute of Psychiatry, Munich

91054

Department of Psychiatry, Universitiy Hospital, Erlangen

93053

Department of Psychiatry, Universitiy Hospital, Regensburg

Unknown

Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital RWTH Aachen, Aachen

Dept. of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT02456948 - Adjunct Minocyline in Treatment-resistant Depression | Biotech Hunter | Biotech Hunter